XML 74 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Equity - USD ($)
Total
Common Stock
Additional Paid- in Capital
Common Shares Held in Deferred Compensation Plan
Deferred Compensation Plan
Deferred Compensation Plan
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2018   61,013,711,000            
Beginning balance at Dec. 31, 2018 $ 1,247,797,000 $ 610,000 $ 1,233,763,000     $ 0 $ 14,185,000 $ (761,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 15,532,000           15,532,000  
Issuance of common stock, net of issuance costs (in shares)   2,184,888,000            
Issuance of common stock, net of issuance costs 87,924,000 $ 22,000 87,902,000          
Repurchase and cancellation of common stock related to employee awards (in shares)   (99,999,000)            
Repurchase and cancellation of common stock related to employee awards (3,959,000)   (3,959,000)          
Issuance of restricted stock (in shares)   30,294,000            
Stock-based compensation 928,000   928,000          
Common stock dividends (15,109,000)           (15,109,000)  
Other comprehensive income 63,000             63,000
Ending balance (in shares) at Mar. 31, 2019   63,128,894,000            
Ending balance at Mar. 31, 2019 1,333,176,000 $ 632,000 1,318,634,000     $ 0 14,608,000 (698,000)
Beginning balance (in shares) at Dec. 31, 2019   67,252,787            
Beginning balance at Dec. 31, 2019 1,517,123,000 $ 673,000 1,514,266,000 $ 0 $ 0   2,621,000 (437,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 12,856,000           12,856,000  
Issuance of common stock, net of issuance costs (in shares)   562,521            
Issuance of common stock, net of issuance costs 29,651,000 $ 4,000 29,647,000          
Repurchase and cancellation of common stock related to employee awards (in shares)   (4,510)            
Repurchase and cancellation of common stock related to employee awards (240,000)   (240,000)          
Issuance of restricted stock (in shares)   20,501            
Stock-based compensation 1,573,000   1,573,000          
Common stock dividends (18,314,000)           (18,314,000)  
Deposits to deferred compensation plan (in shares)   (135,494)   135,494        
Deposits to deferred compensation plan 0   7,346,000   (7,346,000)      
Other comprehensive income 73,000             73,000
Ending balance (in shares) at Mar. 31, 2020   67,695,805            
Ending balance at Mar. 31, 2020 $ 1,542,722,000 $ 677,000 $ 1,552,592,000 $ 135,494 $ (7,346,000)   $ (2,837,000) $ (364,000)